[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3153 Reported in Senate (RS)]
<DOC>
Calendar No. 510
116th CONGRESS
2d Session
H. R. 3153
[Report No. 116-248]
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
July 24, 2019
Received; read twice and referred to the Committee on Commerce,
Science, and Transportation
August 6, 2020
Reported by Mr. Wicker, with an amendment
[Strike out all after the enacting clause and insert the part printed
in italic]
_______________________________________________________________________
AN ACT
To direct the Director of the National Science Foundation to support
research on opioid addiction, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
<DELETED>SECTION 1. SHORT TITLE; FINDINGS.</DELETED>
<DELETED> (a) Short Title.--This Act may be cited as the ``Expanding
Findings for Federal Opioid Research and Treatment Act'' or the
``EFFORT Act''.</DELETED>
<DELETED> (b) Findings.--The Congress finds that--</DELETED>
<DELETED> (1) research gaps currently exist in the
prevention and treatment of opioid addiction;</DELETED>
<DELETED> (2) the National Science Foundation's research on
opioid addiction has increased understanding of the
neuroscience of addiction, substance abuse intervention, the
role of illicit supply networks, the secondary effects on
families, the use of technology to address the opioid epidemic,
and options for alternative, non-addictive therapeutics for
pain; and</DELETED>
<DELETED> (3) the National Science Foundation and the
National Institutes of Health have recognized that fundamental
questions in basic, clinical, and translational research would
benefit greatly from multidisciplinary approaches and
collaboration.</DELETED>
<DELETED>SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.</DELETED>
<DELETED> The Director of the National Science Foundation, in
consultation with the Director of the National Institutes of Health,
shall support merit-reviewed and competitively awarded research on the
science of opioid addiction.</DELETED>
SECTION 1. SHORT TITLE; FINDINGS.
(a) Short Title.--This Act may be cited as the ``Expanding Findings
for Federal Opioid Research and Treatment Act'' or the ``EFFORT Act''.
(b) Findings.--Congress finds that--
(1) research gaps exist in the prevention and treatment of
opioid addiction;
(2) the National Science Foundation's research on opioid
addiction has increased understanding of the neuroscience of
addiction, substance abuse intervention, the role of illicit
supply networks, the secondary effects on families, the use of
technology to address the opioid epidemic, and options for
alternative, non-addictive therapeutics for pain; and
(3) the National Science Foundation and the National
Institutes of Health have recognized that fundamental questions
in basic, clinical, and translational research would benefit
greatly from multidisciplinary approaches and collaboration.
SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.
(a) In General.--The Director of the National Science Foundation,
in consultation with the Director of the National Institutes of Health,
shall support merit-reviewed and competitively-awarded research on the
science of opioid addiction.
(b) Authorization of Appropriations.--To carry out this section,
there are authorized to be appropriated $10,000,000 for each of fiscal
years 2020 through 2024.
Calendar No. 510
116th CONGRESS
2d Session
H. R. 3153
[Report No. 116-248]
_______________________________________________________________________
AN ACT
To direct the Director of the National Science Foundation to support
research on opioid addiction, and for other purposes.
_______________________________________________________________________
August 6, 2020
Reported with an amendment